| 2025 | ||||||||||||||||||||||||||||||||||||||||||||||||
| <<SEP | OCT | NOV>> | ||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||
The Biopharma Industry in Massachusetts: Emerging Breakthroughs, Global Opportunities / TiE
Speaker:
Dr. Una S. Ryan, Chairman, Massachusetts Biotech Council and CEO, Avant Immunotherapeutics
The last 10 years have seen a massive transformation of the biotech and pharmaceuticals industry in Massachusetts. From the shores of Cambridge stretching out across the state, the landscape is now dotted with leading biopharma companies such as Abbott, AstraZeneca, Merck, Novartis, and Pfizer. Massachusetts is also now the home to 280 biotech companies. Biopharma has become a critical economic engine for the state, generating high paying jobs that have accounted for over 50% of the net job growth in the state in the past decade.
Date: 04/18/2006
Location: Cambridge Marriott, Cambridge, MA
Time: 6:30 pm - 9:30 pm
Web: http://boston.tie.org/
|
|